Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
Context: Hypoactive sexual desire disorder (HSDD) is one of the most common sexual problems reported by women, but few studies have been conducted to evaluate treatments for this condition. Objective: The objective of this study was to evaluate the efficacy and safety of a testosterone patch in surgically menopausal women with HSDD. Design: The design was a randomized, double-blind, parallel-group, placebo-controlled, 24-wk study (the Intimate SM 1 study). Setting: The study was performed at private or institutional practices. Patients: The subjects studied were women, aged 26–70 yr, with HSDD after bilateral salpingo-oophorectomy who were receiving concomitant estrogen therapy. Placebo (n = 279) or testosterone 300 μg/d (n = 283) was administered. There were 19 patients who withdrew due to adverse events in the placebo group and 24 in the 300 μg/d testosterone group. Intervention: Testosterone (300 μg/d) or placebo patches were applied twice weekly. Main Outcome Measure(s): The primary end point was the change in the frequency of total satisfying sexual activity at 24 wk. Secondary end points included other sexual functioning end points and safety assessments. Results: At 24 wk, there was an increase from baseline in the frequency of total satisfying sexual activity of 2.10 episodes/4 wk in the testosterone group, which was significantly greater than the change of 0.98 episodes/4 wk in the placebo group (P = 0.0003). The testosterone group also experienced statistically significant improvements in sexual desire and a decrease in distress. The overall safety profile was similar in both treatment groups. Conclusion: In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another androgen (testosterone) also improves sexual function in surgically menopausal women (55,56).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [56]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954 · cited 1×
“01 300 g/d 271 7 [0, 14] 143 19 [9, 36] Androstenedione [50–250 ng/dl] Placebo 276 58 [32, 108] 157 52 [21, 87] 0.”
Self-citationSherwin, B. B., Gelfand, M. M., & Brender, W. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00004 · Cited by 547 · cited 1×
“5] Total testosterone [12–50 ng/dl] Placebo 279 17 [8, 28] 219 16 [7, 28] 0.”
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394
Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902317586001 · Cited by 289
HORMONAL DYNAMICS ASSOCIATED WITH THE MENOPAUSE
Judd, H. L. (1976) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-197612000-00005 · Cited by 158
LORENZO, E. M. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-31-5-556 · Cited by 131
Psychological Reactions and Sexual Life after Hysterectomy with and without Oophorectomy
Nathorst-Böös, J., & von Schoultz, B. (1992) · Gynecologic and Obstetric Investigation · doi:10.1159/000292735 · Cited by 126
DEROGATIS, L., RUST, J., GOLOMBOK, S., BOUCHARD, C., NACHTIGALL, L., RODENBERG, C., KUZNICKI, J., & MCHORNEY, C. A. (2004) · Journal of Sex & Marital Therapy · doi:10.1080/00926230490247183 · Cited by 121
Self-citationSexual response after hysterectomy-oophorectomy: Recent studies and reconsideration of psychogenesis
ZUSSMAN, L., Zussman, S., Sunley, R., & Bjornson, E. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90730-4 · Cited by 103
Cited by
Items 201–300 of 472
Management strategies in SSRI-associated sexual dysfunction in women at midlife
Fooladi, E., Bell, R. J., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.658461 · Cited by 27
Self-citationBloch, M., Meiboom, H., Zaig, I. F., Schreiber, S., & Abramov, L. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.004 · Cited by 28
“The administration of testosterone to women with HSDD after oophorectomy is clearly beneficial (Shifren et al., 2000; Simon et al. 2005), as well as testosterone administration in hypogonadal men (Wang et al.”
BackgroundTwo novel combined drug treatments for women with hypoactive sexual desire disorder
Poels, S., Bloemers, J., van Rooij, K., Koppeschaar, H. P. F., Olivier, B., & Tuiten, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.002 · Cited by 27
Tucker, P. E., & Cohen, P. A. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000943 · Cited by 24
Role of hormones in hypoactive sexual desire disorder and current treatment
AlAwlaqi, A., Amor, H., & Hammadeh, M. E. (2017) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2017.0071 · Cited by 29
“As a result, there was an increase in sexual episodes with the use of the therapy compared with placebo (95).”
MethodResultPrescribing testosterone and DHEA: The role of androgens in women
Smith, T. L., & Batur, P. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20030 · Cited by 34
“8,27 36 The patch signifi cantly increased sexual desire and sexually satisfying events while decreasing sexual-related distress (in 3 of 4 studies) compared with placebo.”
BackgroundMaserejian, N. N., Parish, S. J., Shifren, J. L., Huang, L., Gerstenberger, E. P., & Rosen, R. C. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.2152 · Cited by 26
“Treatments for HSDD Prescription medication 67 (20) 42 (19) 25 (22) Hormonal medication 61 (18) 37 (17) 24 (21) Testosterone 35 (10) 23 (10) 12 (10) Gel or cream 20 (6) 11 (5) 9 (8) Injection 2 (1) 2 (1) 0 Oral 6 (2) 3 (1) 3 (3) Unspecified 8 (2) 7 (3) 1 (1) Estrogen 45 (13) 25 (11) 20 (17) Vaginal 31 (9) 16 (7) 15 (1…”
Effects of testosterone therapy for women: a systematic review and meta-analysis protocol
Islam, R. M., Bell, R. J., Green, S., & Davis, S. R. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0941-8 · Cited by 25
“Testosterone is administered to postmenopausal women with concurrent estrogen [7, 8] or estrogen plus progestogen therapy [9, 10] or to premenopausal women [11, 12], and postmenopausal women not using other sex steroid therapy [13].”
BackgroundSelf-citationClinical Application of CNS-Acting Agents in FSD
Perelman, M. A. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00611.x · Cited by 28
Pharmacotherapy for women's sexual dysfunction
Basson, R. J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903004184 · Cited by 25
“Recently, four 6 month studies of surgically post menopausal women and one of naturally menopausal women receiving transdermal testosterone have been conducted by the same sponsor using the same protocol to show modest benefit from the 300 μg but not the 450 μg daily dose [43-47].”
MethodFemale sexual dysfunction in postmenopausal women
Castelo‐Branco, C., Hidalgo, M. J. C., & Chedraui, P. A. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.6.639 · Cited by 27
“The administration of 300 μg/day of testosterone as a transdermal patch to postmenopausal women who had undergone hysterectomy and oophorectomy and were on estrogen replacement improved sexual function and psychological well-being [57-59,103] .”
BackgroundWorsley, R., Robinson, P. J., Bell, R. J., Moufarege, A., & Davis, S. R. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318279bd4a · Cited by 25
“5 (24-75) [13-98] Bioavailable testosterone, ng/dL 560 2.”
Self-citationThe Safety of Postmenopausal Testosterone Therapy
Maclaran, K., & Panay, N. (2012) · Women s Health · doi:10.2217/whe.12.11 · Cited by 27
“Other studies using oral testosterone therapy also failed to demonstrate any effect on glucose metabolism [71], and physiological replacement using the TTP has been shown to have no detrimental effects on glucose metabolism [25,26,29,36].”
BackgroundAndrogen-based therapies in women
Whitton, K., & Baber, R. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101783 · Cited by 25
Pitkin, J. (2008) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.10.011 · Cited by 30
Gregersen, N., Jensen, P. T., & Giraldi, A. G. E. (2006) · PubMed · Cited by 24
Categories of Female Sexual Dysfunction
Amato, P. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2006.10.003 · Cited by 27
Thrombosis in Three Postmenopausal Women Receiving Testosterone Therapy for Low Libido
Glueck, C. J., Bowe, D., Valdez, A., & Wang, P. (2013) · Women s Health · doi:10.2217/whe.13.31 · Cited by 23
“T transdermal patches have been reported to safely improve libido in 24-week blind trials of estrogen-using postmenopausal women who have had bilateral oophorectomy [14–16], and to improve sexual function in some women with natural menopause not taking estrogen [13,17,18].”
BackgroundSexual Dysfunction in Women With Kidney Disease
Ali, S., & Dave, N. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2020.07.005 · Cited by 22
Buggio, L., Barbàra, G., Facchin, F., Ghezzi, L., Dridi, D., & Vercellini, P. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2016693 · Cited by 28
“The adverse effects on female sexuality of low testosterone levels are mostly derived from studies involving menopausal women with sexual dysfunctions [87].”
BackgroundKrapf, J. M., & Simon, J. A. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000863 · Cited by 27
Self-citationCombination of Testosterone and Vardenafil Increases Female Sexual Functioning in Sub-Primed Rats
Snoeren, E. M. S., Bovens, A. A., Refsgaard, L. K., Westphal, K. G. C., Waldinger, M. D., Olivier, B., & Oosting, R. S. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02177.x · Cited by 24
Androgen insufficiency in women
Braunstein, G. D. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.03.009 · Cited by 26
Self-citationDavey, D. A. (2012) · Women s Health · doi:10.2217/whe.12.27 · Cited by 29
“In the INTIMATE SM1 24-week trial of 562 women with HSDD following bilateral oophorectomy, sexual function increased by 74% in women treated with T compared with 33% in the placebo group, distress decreased by 65% in the T treated group compared with 40% in the placebo group [61].”
ResultThe timing of estrogen therapy after ovariectomy—implications for neurocognitive function
Maki, P. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0901 · Cited by 21
“and androgen treatment improves sexual function in surgically menopausal women”
BackgroundA 60-Year-Old Woman With Sexual Difficulties
Potter, J. E. (2007) · JAMA · doi:10.1001/jama.297.6.620 · Cited by 24
Flibanserin for hypoactive sexual desire disorder: place in therapy
Gelman, F., & Atrio, J. (2017) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622316679933 · Cited by 21
Assessment of premature menopause on the sexual function and quality of life in women
Javadpour, S., Sharifi, N., Mosallanezhad, Z., Rasekhjahromi, A., & Jamali, S. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1871894 · Cited by 25
Garz, M., Schröder, J., Nieder, T. O., Becker-Hébly, I., Biedermann, S. V., Hildebrandt, T., Briken, P., Auer, M. K., & Fuß, J. (2021) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2021.1888831 · Cited by 23
“…desire was chosen as an outcome because of its high clinical relevance in diagnosis of sexual dysfunctions and particularly sexual desire disorders (American Psychiatric Association, 2013) in which hormonal dysregulations can be a cause and therefore be of relevance under GAT (Simon et al., 2005).”
BackgroundTestosterone positively regulates vagina NO-induced relaxation: an experimental study in rats
Cellai, I., Filippi, S., Comeglio, P., Cipriani, S., Maseroli, E., Stasi, V. D., Todisco, T., Marchiani, S., Tamburrino, L., Villanelli, F., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01743-4 · Cited by 20
Testosterone and the heart: friend or foe?
Davis, S. R. (2023) · Climacteric · doi:10.1080/13697137.2023.2250252 · Cited by 21
Self-citationAndrogens and breast cancer risk
Kenemans, P., & van der Mooren, M. J. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.651925 · Cited by 21
Challenges in the Gynecologic Care of Premenopausal Women With Breast Cancer
Bakkum-Gamez, J. N., Laughlin, S. K., Jensen, J. R., Akogyeram, C. O., & Pruthi, S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0794 · Cited by 22
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00020-1 · Cited by 24
LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause
Nappi, R. E., Lello, S., Melis, G. B., Albani, F. L. M., Polatti, F., & GENAZZANI, A. R. (2009) · Climacteric · doi:10.3109/13697130902972005 · Cited by 20
Review of drug treatment for female sexual dysfunction
Wylie, K. R., & Malik, F. (2009) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.009206 · Cited by 20
History of androgens and androgen action
Handelsman, D. J. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101629 · Cited by 22
Cardiovascular Physiology of Androgens and Androgen Testosterone Therapy in Postmenopausal Women
Ling, S., Komesaroff, P. A., & Sudhir, K. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582414 · Cited by 19
“[70] Simon, J.”
BackgroundEverhov, A. H., Rådestad, A. F., Nyberg, T., Smedby, K. E. E., Bergmark, K. H., & Hirschberg, A. L. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.022 · Cited by 21
Anderson, R. C., & Moffatt, C. E. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.01.001 · Cited by 20
Distressing Sexual Function at Midlife: Unmet Needs, Practical Diagnoses, and Available Treatments
Simon, J. A., & Lukas, V. A. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002268 · Cited by 24
Self-citationThe Saga of Testosterone for Menopausal Women at the Food and Drug Administration (FDA)
Simon, J. A., & Kapner, M. D. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.01.009 · Cited by 19
Self-citationPesantez, G. S. P., & Clayton, A. H. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200039 · Cited by 19
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
“Despite these results [108–110, 112], FDA has not approved due to lack of long-term safety”
ResultEffect Size in Efficacy Trials of Women With Decreased Sexual Desire
Pyke, R. E., & Clayton, A. H. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.01.003 · Cited by 18
New lifestyle drugs and somatoform disorders in dermatology
Harth, W., Seikowski, K., Hermes, B., & Gieler, U. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02507.x · Cited by 17
Androgen therapy in women: What we think we know
Drillich, A., & Davis, S. R. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.02.005 · Cited by 20
Self-citationSexual dysfunction and depression in premenopausal women with mucocutaneous Behçet's disease
Yetkin, D. Ö., Celik, O., Hatemi, G., & Kadıoğlu, P. (2012) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12005 · Cited by 20
Testosterone Supplementation for Hypoactive Sexual Desire Disorder in Women
Woodis, C. B., McLendon, A. N., & Muzyk, A. J. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1004 · Cited by 17
Javadivala, Z., Khoei, E. M., Jafarabadi, M. A., Allahverdipour, H., Mirghafourvand, M., Nadrian, H., & Kouzekanani, K. (2018) · Sexual & Relationship Therapy · doi:10.1080/14681994.2018.1446515 · Cited by 18
“…2006; Panay et al., 2010; Panjari et al., 2009; Savolainen-Peltonen, Hautamaki, Tuomikoski, Ylikorkala, & Mikkola, 2014; Shifren et al., 2000, 2006; Simon et al., 2005; Welton et al., 2009; Wiklund, Karlberg, & Mattsson, 1993; Yang, Wang, Chen, Chang, & Yuan, 2004; Ziaei et al., 2010),…”
Effect of Premature Menopause on Sexuality
Graziottin, A. (2007) · Women s Health · doi:10.2217/17455057.3.4.455 · Cited by 21
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A. G. E., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., et al. (2021) · Climacteric · doi:10.1080/13697137.2021.1891773 · Cited by 20
“Despite the lack of evidence for cardiovascular events or breast cancer in randomized, placebo-controlled clinical trials of testosterone in postmenopausal women with HSDD [11,12], the regulators had concerns about these risks, given the results of the Women’s Health Initiative [13,14].”
ResultSelf-citationSchwartz, E., & Holtorf, K. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.07.013 · Cited by 16
The Safety of Testosterone Therapy in Women
Al-Imari, L., & Wolfman, W. (2012) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35385-3 · Cited by 19
Managing Low Sexual Desire in Women
Maclaran, K., & Panay, N. (2011) · Women s Health · doi:10.2217/whe.11.54 · Cited by 18
Sexual arousal and response — the psychosomatic circle
Bancroft, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-05161-6.00004-5 · Cited by 20
Care of Women in Menopause: Sexual Function, Dysfunction and Therapeutic Modalities
Mattar, C. N. Z., Chong, Y. S., Su, L., Agarwal, A. A., Wong, P., & Choolani, M. A. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n3p215 · Cited by 23
Androgen deficiency and therapy in women
Mathur, R., & Braunstein, G. D. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833ab083 · Cited by 16
Self-citationPhysiological Effects of Androgens in Women
Hodgson, T. K., & Braunstein, G. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_4 · Cited by 18
Self-citationTestosterone replacement therapy
Seal, L. (2009) · Medicine · doi:10.1016/j.mpmed.2009.06.002 · Cited by 16
Treatments and Management of Menopausal Symptoms: Current Status and Future Challenges
Comparetto, C., & Borruto, F. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2303248 · Cited by 23
Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women
Chaikittisilpa, S., Soimongkol, K., & Jaisamrarn, U. (2019) · Climacteric · doi:10.1080/13697137.2019.1577378 · Cited by 17
Breast and cervical cancer in transgender men: literature review and a case report
Lisa, F. S. D., Villa, A., Filomeno, L., Arcuri, T., Chiofalo, B., Sanguineti, G., Pizzuti, L., Krasniqi, E., Barba, M., Sergi, D., et al. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241259466 · Cited by 14
“26 29 Conversely, the use of testosterone in premenopausal women is not advisable, due to lack of supporting evidence.”
BackgroundVoice Change Following Testosterone Supplementation in Women: A Multi-Institutional Case Series
Chadwick, K. A., Simpson, C. B., McGarey, P. O., Estes, C. M., Nix, J. P., & Sulica, L. (2020) · Journal of Voice · doi:10.1016/j.jvoice.2020.03.008 · Cited by 14
Women Express a Preference for Feminized Male Faces after Giving Birth
Escasa-Dorne, M. J., Manlove, H. A., & Gray, P. B. (2016) · Adaptive Human Behavior and Physiology · doi:10.1007/s40750-016-0048-6 · Cited by 13
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Ganesan, K., Habboush, Y. Y., & Sultan, S. (2018) · Cureus · doi:10.7759/cureus.2401 · Cited by 20
Tavares, M. C. H., Topic, B., Abreu, C. T., Waga, I., Gomes, Ú. R., Tomaz, C. A. B., & Mattern, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.004 · Cited by 15
Renke, G., & Tostes, F. (2023) · Pharmaceuticals · doi:10.3390/ph16040619 · Cited by 15
Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians
Cocchetti, C., Ristori, J., Mazzoli, F., Vignozzi, L., Maggi, M., & Fisher, A. D. (2021) · International Journal of Impotence Research · doi:10.1038/s41443-021-00409-8 · Cited by 15
Female sexual dysfunction: what's new?
Mayer, M. E., Bauer, R. M., Schorsch, I., Sonnenberg, J. E., Stief, C. G., & Ückert, S. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f1c733 · Cited by 12
Endocrine Aspects of Chronic Kidney Disease
Carrero, J. J., Stenvinkel, P., & Lindholm, B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10057-0 · Cited by 14
Pathophysiology and Medical Management of Hypoactive Sexual Desire Disorder
Clayton, A. H., & Vignozzi, L. (2018) · Wiley eBooks · doi:10.1002/9781119266136.ch6 · Cited by 15
Hickey, M., Trainer, A. H., Krejany, E. O., Brand, A. H., Domchek, S. M., Soo, V. P., Braat, S., & Mishra, G. D. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.10.007 · Cited by 13
Testosterone therapy and other treatment modalities for female sexual dysfunction
Ingram, C., Payne, K. S., Messore, M., & Scovell, J. M. (2020) · Current Opinion in Urology · doi:10.1097/mou.0000000000000759 · Cited by 12
Testosterone for women: certainties and uncertainties
Davis, S. R. (2022) · Climacteric · doi:10.1080/13697137.2022.2146492 · Cited by 13
“[13] provided the foundation of the research program focused on a patch releasing 300 lg of testosterone daily for the treatment of low libido in oophorectomized women on oral estrogen therapy [15,16].”
BackgroundSelf-citationAlexandre, M., Black, J., Whicker, M. E., Minkin, M. J., & Ratner, E. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.06.003 · Cited by 15
Testosterone for midlife women: the hormone of desire?
Shifren, J. L. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000540 · Cited by 12
Potential future options in the pharmacotherapy of female sexual dysfunction
Ückert, S., Mayer, M. E., Udo Jonas, A., & Stief, C. G. (2006) · World Journal of Urology · doi:10.1007/s00345-006-0121-z · Cited by 11
“SigniWcantly increased levels of bioavailable and free testosterone were registered as well as improved sexual desire, a higher frequency of satisfying sexual activity and decreased personal distress [7, 8 ].”
BackgroundLate‐stage clinical development in lower urogenital targets: sexual dysfunction
Azam, U. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706638 · Cited by 11
“This study has recently been replicated in a larger setting (Braunstein et al., 2005).”
MethodResultTestosterone for Treating Female Sexual Dysfunction
Simon, J. A., & Ohleth, K. M. (2024) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000916 · Cited by 11
“36,40,43 Breast density, when used as a surrogate marker for breast cancer risk, did not change with transdermal testosterone in a meta-analysis of data from over 3000 women using transdermal testosterone, alone or with concomitant estrogen and progestin hormone therapy.”
InfluentialSelf-citationHoz, F. J. E. D. L. (2019) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.20.1.3388.2020 · Cited by 10
“(36) con el uso de la tes-tosterona, en mujeres en climaterio, que están recibiendo terapia de reemplazo hormonal, y que presentan trastorno del deseo sexual.”
The behavioral correlates of testosterone
Bancroft, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.006 · Cited by 12
Reproductive Aging of Females: Neural Systems
Brinton, R. D., Gore, A. C., Schmidt, P. J., & Morrison, J. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00068-1 · Cited by 12
Female Sexual Dysfunction: Is It a Treatable Disease?
Houman, J., Feng, T., EILBER, K. S., & Anger, J. T. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0583-5 · Cited by 10
Role of androgens in modulating male and female sexual function
Traish, A. M. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.052 · Cited by 9
Women's expectations and experiences of hormone treatment for sexual dysfunction
Fooladi, E., Bell, R. J., Whittaker, A. M., & Davis, S. R. (2014) · Climacteric · doi:10.3109/13697137.2014.926322 · Cited by 10
Self-citationPastoor, H., Both, S., Timman, R., Laan, E. T. M., & Laven, J. S. E. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.07.002 · Cited by 10
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Waldman, T., SHUFELT, C. L., & Braunstein, G. D. (2012) · Clinical Investigation · doi:10.4155/cli.12.18 · Cited by 8
Self-citationSexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause
Rech, C. M. Z., Clapauch, R., & Bouskela, E. (2019) · Journal of Women s Health · doi:10.1089/jwh.2017.6905 · Cited by 8
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Should testosterone be added to estrogen-progestin therapy for breast protection?
Burger, H. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31802cdddd · Cited by 9
Sexual Concerns–Menopause and Sexual Function
Basson, R. J. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32080-1 · Cited by 8
A current perspective into young female sex hormone replacement: a review
Giordano Imbroll, M., & Gruppetta, M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1816820 · Cited by 7
Androgen therapy for women after menopause
Marko, K. I., & Simon, J. A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101592 · Cited by 12
Self-citationAndrogens in postmenopausal women
Vigneswaran, K., & Hamoda, H. (2022) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12836 · Cited by 9
Tratamiento del deseo sexual hipoactivo de la mujer
Santamaría, F. C. (2007) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(07)74031-1 · Cited by 12
Instrument Development and Validation
Rodenberg, C., Kuznicki, J. T., & Yiu, G. H. (2018) · doi:10.1201/9781351110273-130001104 · Cited by 7
Self-citationRowen, T. S., Davis, S. R., Parish, S. J., Simon, J. A., & Vignozzi, L. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.12.013 · Cited by 9
Self-citationHartmann, U. H., & Rüffer-Hesse, C. (2006) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-007-0113-9 · Cited by 8
“26 | Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 1 · 2007 – anders als bei der oralen Behandlung mit Methyltestosteron – unbeeinflusst [45, 45, 47].”
Background
Metadata
- Authors
- Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., Waldbaum, A., Bouchard, C., Derzko, C., Buch, A., Rodenberg, C., Lucas, J., & Davis, S.
- Affiliations
- Women’s Health Research Center (J.S.), Laurel, Maryland 20707;
- Cedars-Sinai Medical Center (US)
- New York University (US)
- Rapid Medical Research (US)
- Katz, Kade, and Hewitt, Inc. (M.K.), Cincinnati, Ohio 45219;
- S. A. M. Clinical Research Center (S.M.), San Antonio, Texas 78229;
- Downtown Women's Health Care (US)
- Clinique RSF, Inc. (C.B.), Quebec, Canada G1S 2L6;
- St. Michael's Hospital (CA)
- Procter & Gamble (United States) (US)
- Jean Hailes (AU)
- Corresponding author
- Simon, James
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-09-01
- Volume
- 90
- Issue
- 9
- Pages
- 5226-5233
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041293595
- Semantic Scholar
- 26f1f458c86409345ab57bb45f0ed0c5705b02c2
- Cited by
- 475
- References
- 17
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 15 · 2021: 23 · 2020: 20 · 2019: 13 · 2018: 22 · 2017: 25 · 2016: 18 · 2015: 13 · 2014: 17 · 2013: 19 · 2012: 35
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone patch, hypoactive sexual desire disorder, surgical menopause, sexual desire, sexual activity, sexual dysfunction, salpingo-oophorectomy, estrogen therapy, testosterone replacement therapy, treatment safety
- MeSH terms
- Administration, Cutaneous, Androgens, Double-Blind Method, Female, Humans, Libido, Menopause, Premature, Sexual Behavior, Gynecologic Surgical Procedures, Testosterone, Treatment Outcome, Sexual Dysfunctions, Psychological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.